zing logo

4th Zing Drug Discovery Conference 2014

This webpage is for a conference which has already taken place and is for informational purposes only.
Maintainence is not ongoing for this page and most Links have been disabled.
To view a full list of our upcoming conferences please use the following link

2nd International Conference on Global Challenges for New Drug Discovery Against Tropical Parasitic Diseases


The tropical parasitic diseases are responsible for staggering morbidity and millions of deaths every year, especially in the tropical regions of the word. Although incidences of these diseases are mostly centered in tropical regions the socioeconomic and public health impacts of tropical parasitic diseases are global. More then half of the world’s population is currently under the risk of being exposed to the infection with one or the other tropical disease pathogens. Emergence and spread of drug-resistant and more virulent strains of the parasites have further intensified the problem. Despite of the heavy burden on humanity the tropical parasitic diseases have been mostly ignored in relation to advances in modern drug discovery and only few new antipatasitic drugs have been developed during last several years.

Improved global attention with increasing funding opportunities through public and non-profit organizations as well as emergence of public-private partnerships for development of strategies to monitor, treat, control and eliminate neglected tropical parasitic diseases have generated unprecedented interests in new programs on discovery and development of drugs/vaccines. Significant increase in global business practices and leisure travel to the endemic counties require effective measures to protect the transient population from getting afflicted with the tropical parasitic diseases.

This conference shall focus on multidisciplinary efforts directed against control, treatments and elimination of neglected parasitic diseases namely, (a) Socioeconomic and public awareness programs in neglected tropical infectious diseases; (b) Monitoring, containment and treatment of drug resistant cases; (c) Translational research to evaluate new drugs and drug combinations (d) Molecular targets-based and structure-based medicinal chemistry approach to maintain healthy drug-discovery pipelines and (e) Opportunities to develop multidisciplinary programs and current funding opportunities.

IJPDDRIn conjunction with the conference, the International Journal for Parasitology: Drugs and Drug Resistance (IJP:DDR), an open access journal, will publish a special issue dedicated to research on drug discovery against parasitic diseases. Attendees are therefore encouraged to submit original scientific manuscripts in the subject area to the journal to be considered for publication in the special issue. All manuscripts will undergo peer-review and must meet the normal standards for publication in IJP:DDR.

The deadline for consideration of a submitted manuscript is May 1st, 2014, but authors are encouraged to submit earlier, so as to help speed the review process. It is anticipated that the special issue of IJP:DDR will be published in fall 2014. Submit my manuscript

Potential Speakers- Leading experts from academia, pharmaceutical companies, public-government agencies, non-profit agencies and private-public partnerships.

Target Audience- Researchers and students from Academic institutions, pharmaceutical companies with global health portfolio; Officials and policy makers from government agencies and non-profit organizations.

Register Now

Conference Programme

Conference Programme
Please Note: This Programme is liable to change and will be updated regularly. We strongly recommend periodically reviewing this document.

Conference Sponsors


The Conference Chairs

Babu L. Tekwani
University of Mississippi

        • Principal Scientist in the National Center for Natural Products Research
        • Coordinator, UM/WRAIR Discovery Program
        • Professor of Pharmacology
Peter Myler
Seattle Biomedical Research Institute

  • Full Professor, Seattle Biomedical Research Institute
  • Research Professor, Department of Global Health, Department of Medical Education and Biomedical Informatics, University of Washington

  • Abstract Submission Deadlines

    Talk Consideration – 19th November 2013
    Poster Deadline – 17th December 2013

    Abstract Information Abstract Template Word Format Abstract Template .pdf Format

    The Venue

    Parador de Nerja
    Nerja, Malaga. Spain



    17th February 2014 – 20th February 2014

    This contemporary Parador is situated on a cliff overlooking the beach and ocean, with a pleasant lawn complete with chaises and umbrellas where you can feel away from the madding-crowd below. You can choose to swim in the Parador’s swimming pool or take the private glass elevator/lift down to the beach. With bright and spacious common areas featuring works of art by well-known contemporary artists Bajola, Belén Comthe and Dario Basso; this property has a particularly pleasing ambiance and is the perfect location to absorb the scientific content of the conference and unwind during  free-time.


    Transfers & Tours

    Venue Rating****
    Nearest AirportMálaga Airport
    Transfers & ToursView Details


    Plenary Speakers


    Larry Walker
    University of Mississippi

    The safety and efficacy of 8-aminoquinolines: new insights from metabolism and structure-activity considerations


    Rosemary Rochford
    SUNY Upstate Medical University

    Use of humanized SCID mouse models for anti-malaria drug evaluation


    Simon Croft
    London School of Hygiene and Tropical Medicine

    Challenges And Opportunities For The Development Of New Treatments For Leishmaniasis


    Steve A Ward
    Liverpool School of Tropical Medicine

    A•WOL drug discovery – Hit identification and lead optimisation of novel compounds with efficacy against Wolbachia endosymbionts of filarial nematodes


    R. Luise Krauth-Siegel
    University of Heidelberg

    The Trypanothione System – Which opportunities does the Parasite-Specific Pathway Offer for a Target-Based Drug Development?

    Invited Speakers

    SpeakerAffiliationPresentation Title
    Manuel FresnoUniversidad Autonoma de MadridImmunotherapy‚ an Alternative Approach to Treat Neglected Protozoan Diseases
    Pradeep DasIndian Council of Medical ResearchTo Be Confirmed
    Rafael Balana-Fouce Universidad de LeonDNA Topoisomerase IB in Leishmania; A Pivotal Target for Drug Development
    Sanjeev Krishna St George’s University of LondonArtemisinin resistance: dogmas and antidogmas
    Vicky Avery Griffith UniversityHTS Approaches in Parasitology:  Challenges and Successes
    Hugo CerecettoUniversidad de la República – UruguayLooking for New Anti-T. Cruzi Drugs: Surpassing the “Hit-To-Lead” Phase
    Rentala MadhubalaJawaharlal Nehru UniversityAminoacyl tRNA synthetases and their paralogs from Leishmania: Novel anti-leishmanial drug targets
    Zlatko JanebaInstitute of Organic Chemistry and Biochemistry AS CRPotential Role of Acyclic Nucleoside Phosphonates in the Treatment of Malaria
    Rosa M RegueraUniversidad de LeónFluorescent imaging in Leishmania investigation; a trend for new challenges
    Thomas KurzHeinrich-Heine-UniversityIspC as target for antiplasmodial drug discovery: Synthesis‚ enantiomeric separation and structural biology of reverse fosmidomycin derivatives
    Mercedes GonzálezUniversidad de la República – UruguayGetting insight on the mode of action of anti-T.cruzi agents: from metabolimic to death mechanism studies
    Adam RensloUniversity of CaliforniaAntimalarial Peroxides: Mechanistic Studies and Next-Generation Drug Delivery Systems
    Achim Schnaufer University of EdinburghMitochondrial Gene Expression as a Target for Novel and Existing Anti-Trypanosomatid Therapies
    Amit SharmaInternational Centre for Genetic Engineering and BiotechnologyInsights into Inhibitor Discovery against Malaria Parasite Proteins
    Andrew Knox Trinity College DublinPutting African Sleeping Sickness to Bed – Rational and Drug Repositioning Approaches
    David Wright Vanderbilt UniversityEffect of Antimalarials on Heme Speciation in the Malaria Parasite Plasmodium falciparum
    Inigo Angulo BarturenGlaxoSmithKlineNew Paradigms to Use Animal Models as Drug Discovery Accelerators
    Kiaran Kirk The Australian National UniversityTargeting ion transport in the malaria parasite with new-generation antimalarials
    Manu De Rycker University of DundeeHit Discovery Approaches for Trypanosomatid Diseases
    Robert T. Jacobs Anacor Pharmaceuticals Inc.Antiparasitic Activities of Novel Boron Containing Heterocycles: Discovery and Development of New Treatments for Human African Trypanosomiasis‚ Malaria and Filariasis
    Mahmoud A. ElSohlyElSohly Laboratories IncFrom  pharmocognosy of Artemisia annua to targeted therapy with orally active artemisinin dimers
    Sanjay A. DesaiNational Institute of Allergy & Infectious DiseasesTargeting ion and nutrient uptake by erythrocytes infected with malaria parasites
    Philippe ChristenUniversity of GenevaReverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana
    Dolores Gonzalez-PacanowskaInstituto de Parasitología y BiomedicinaCarbohydrate-binding agents act as potent trypanocidals that elicit modifications in VSG glycosylation
    David WatersonMMVMedicines for Malaria Venture’s Drug Discovery Portfolio
    Hira NakhasiUS Food & Drug AdministrationUfm1 mediated protein modification pathway as drug target in the human protozoan parasite Leishmania donovani

    Contributing Speakers

    Vicente Larraga – Spanish Research Council
    Kevin Saliba – The Australian National University
    Nicholas Malmquist – Pasteur Institute
    Mitchell Avery – University of Mississippi
    Laura Maria Sanz-Alonso – GSK

    Conference Programme

    Conference Programme
    Please Note: This Programme is liable to change and will be updated regularly. We strongly recommend periodically reviewing this document.

    Conference Fees

    StandardAccompanying Adult Accompanying ChildExtra Night AdultExtra Night Child
    Conference Day Pass€750
    Registration & Payment DeadlineJan 16 2014Jan 16 2014Jan 16 2014Jan 16 2014Jan 16 2014

    Conference Day Pass : Price includes conference registration and attendance, lunches, coffee breaks and the Gala Night. This option does not include evening meals or accommodation.

    Delegate Fees: Include conference registration and attendance, accommodation, all meals on a specially negotiated full-board package and The Gala Night (including any accompanying persons).

    Accompanying Persons Fees: Include the same specially negotiated full-board package as delegates excluding conference attendance.

    Group Discounts: Special discounts are offered for group bookings of 6 or more students from the SAME lab. Please contact us for more information

    Additional Night Fees: Prices are per person per night on a Bed & Breakfast basis. Spaces are extremely limited so we encourage you to notify us immediately should you require additional nights at this venue

    Children: Children aged 12 and above are regarded as adults by the hotel. Children under the age of 2 years stay free of charge.


    Please Note: Your accommodation will not be reserved and conference registration is not confirmed until Zing Conferences Ltd have received full payment of all outstanding fees.


    Conference Sponsors


    Register Now